AGM
TLSIW icon

Alpine Global Management’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Alpine Global Management’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-11,600
Closed -$1K – 397
2022
Q4 		$1K Hold
11,600
– – ﹤0.01% 459
2022
Q3 		$1K Buy
+11,600
New +$829 ﹤0.01% 413

Other funds holding TLSIW

Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
Radcliffe Capital Management
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
Vestcor Inc
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.56% 1-Year Est. Return
MP
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Alpine Global Management's TLSIW Position: Q1 2023 in Review

Alpine Global Management sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2023, closing a stake of 11,600 shares — an estimated $1K sold.

Alpine Global Management first reported a position in TLSIW in Q3 2022 and held it in 2 quarters. The position peaked at $1K in Q4 2022. 24 funds tracked by Wall St. Rank hold TLSIW as of Q1 2023.

  • Alpine Global Management reported no remaining TriSalus Life Sciences Warrant position as of Q1 2023 after selling out during the quarter.
  • Alpine Global Management sold 11,600 TriSalus Life Sciences Warrant shares in Q1 2023, an estimated $1K.
  • Alpine Global Management first reported a position in TriSalus Life Sciences Warrant in Q3 2022 and held it in 2 quarters.
  • Alpine Global Management's TriSalus Life Sciences Warrant position peaked at $1K in Q4 2022.
  • 24 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2023.

Based on Alpine Global Management's 13F filing for Q1 2023, filed 15 May 2023.